ALLOX — Seed · €1.8M partial: only one investor's ticket was disclosed

CDTI Innovación announced an equity investment in Allox (Allostery Exploration Technologies) alongside Asabys Partners; the round's total was not disclosed and no lead was named; CDTI Innovación's own commitment was €1.8M (Capital-Riesgo.es). Allox is a spin-off of Barcelona's Centre for Genomic Regulation using multidimensional mutagenesis to map allosteric sites in disease-relevant proteins, initially targeting cancer.